Normal INR Range for Healthy Adults
In healthy adults not receiving anticoagulation, the normal INR is 1.0, with an acceptable range of approximately 0.8–1.2. 1, 2
Understanding the Normal INR Value
The INR was specifically designed and calibrated for monitoring warfarin therapy in patients on stable anticoagulation for at least 6 weeks, not for assessing baseline coagulation in healthy individuals. 2
An INR of exactly 1.0 represents the reference standard by definition, as it reflects the prothrombin time ratio when using the primary international reference thromboplastin (British Comparative Thromboplastin, coded 67/40), which was assigned an International Sensitivity Index (ISI) of 1.0. 1
In practical laboratory medicine, healthy individuals typically demonstrate INR values between 0.8 and 1.2, accounting for normal biological variation and minor analytical imprecision in the measurement system. 1
Critical Clinical Context
The INR becomes clinically meaningful only when values exceed 1.5 in the context of bleeding risk assessment or anticoagulation monitoring. 1 Historical data show that bleeding risk remains low until INR exceeds 5.0, with clinically significant hemorrhage risk appearing above INR 3.5. 3
For patients not on vitamin K antagonists, there is no high-quality evidence supporting specific INR targets or interventions for mildly elevated values in the 1.0–2.0 range. 2 The therapeutic INR targets (such as 1.5,1.7, or 1.8) commonly referenced in clinical practice originated from historical PT ratio ranges used with non-standardized thromboplastins and were never rigorously validated for bleeding prediction. 1
The INR does not reliably predict bleeding risk in patients with liver disease, as it was calibrated using warfarin-treated patients rather than those with hepatic dysfunction, and hemostatic balance in cirrhosis is fundamentally different from warfarin-induced coagulopathy. 4
Common Pitfalls to Avoid
Do not interpret INR values between 1.0 and 1.5 as requiring intervention in non-anticoagulated patients, as this range lacks validated clinical significance for bleeding risk and does not warrant prophylactic plasma transfusion or vitamin K administration. 1, 4
Never assume that INR values are interchangeable between different laboratory methods or point-of-care devices, particularly at higher INR ranges where significant discrepancies can occur due to differences in thromboplastin reagents and ISI calibration. 5, 6
Recognize that the PT ratio (patient PT divided by control PT) is not equivalent to the INR, as the INR incorporates the ISI correction factor to standardize results across different reagents and instruments. 2